Alpelisib Discontinuation in Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer
Breast Cancer Res Treat 2022 Jan 09;[EPub Ahead of Print], YM Cheung, GE Cromwell, SM Tolaney, L Min, ME McDonnellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.